Your browser doesn't support javascript.
loading
Tildrakizumab in real-life shows good efficacy in moderate-to-severe psoriasis regardless of previous use of biologic drugs and joint involvement.
Mastorino, Luca; Cariti, Caterina; Susca, Sara; Sciamarrelli, Nadia; Borriello, Silvia; Ortoncelli, Michela; Stroppiana, Elena; Verrone, Anna; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone.
Afiliação
  • Mastorino L; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Cariti C; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Susca S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Sciamarrelli N; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Borriello S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Ortoncelli M; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Stroppiana E; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Verrone A; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Dapavo P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
  • Ribero S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Dermatol Ther ; 35(11): e15818, 2022 11.
Article em En | MEDLINE | ID: mdl-36097346

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos Limite: Humans Idioma: En Revista: Dermatol Ther Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos Limite: Humans Idioma: En Revista: Dermatol Ther Ano de publicação: 2022 Tipo de documento: Article